When picking the right SPAC partner, it's not price you're after

The sell-side process for SPACs is more limited than a typical M&A process, and in most cases, price isn't the dominating factor when determining the best partner, panelists said at a virtual McDermott Will & Emery conference.

DealsHealthcareFeaturedTop Stories